CIDRAP newsletters options
The comments prompted swift and sharp criticism among some public health experts.
About 9 months after COVID-19 infection, 19% of nonhospitalized adult patients in a German cohort had fatigue, 26% had mild cognitive impairment ("brain fog"), and 1% had moderate cognitive dysfunction, according to a multicenter study.
The study, published late last week in EClinicalMedicine, also showed that the incidence and risk factors for fatigue and cognitive impairment differed by age-group.
In its weekly flu update on Sep 16, the Centers for Disease Control and Prevention (CDC) reported two more variant H1N2 (H1N2v) infections, in Michigan and Wisconsin.
Zero of 313 exposed healthcare workers got monkeypox, even though only 23% wore adequate protective equipment.
After 2 years, 12% had lingering symptoms and 8% had new-onset or worsening symptoms.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
One in three unvaccinated COVID-19 survivors in a Spanish cohort had no detectable SARS-CoV-2 antibodies nearly 1 year after infection, according to a prospective study published today in BMC Medicine.
An analysis of data on patients hospitalized with community-acquired pneumonia (CAP) found that extended-spectrum antibiotic therapy was associated with increased mortality compared with standard antibiotic therapy, Japanese researchers reported yesterday in the International Journal of Infectious Diseases.
"As we implement the interventions that we have, simultaneously, we still pursue some unanswered questions."
The report spares no one the responsibility—including the public—for millions of preventable deaths.
Few laboratories in sub-Saharan Africa conduct bacteriologic testing, and only a fraction of them can evaluate bacteria for antimicrobial resistance.
The Centers for Disease Control and Prevention (CDC) yesterday reported an Escherichia coli O157:H7 outbreak tied to Hello Fresh meal kits that contained contaminated ground beef.
South African researchers report waning monovalent (single-strain) COVID-19 vaccine booster effectiveness against the Omicron subvariants, with estimated efficacy falling to 50% against the BA.1/BA.2 and 47% against BA.4/BA.5 as early as 3 or 4 months after vaccination.
Older COVID-19 survivors may be at a 69% higher risk of developing Alzheimer's within 1 year.
In US news, practitioners describe issues with vaccination due to multiple vaccine products and confusing immunization schedules.
CDC Director Walensky says patients and clinicians likely did not recognize this new infection early on.
SARS-CoV-2 antibodies fell over time after vaccination or COVID-19 infection but were restored with booster doses in West Virginia nursing home residents and staff, and antibody levels were significantly lower during the Delta than the Omicron variant surges in those with breakthrough infections, finds a study published yesterday in JAMA Network Open.
Two men in their 30s developed encephalomyelitis, or inflammation of the brain and spinal cord.
A second study shows a 41% reduction in long COVID among vaccinated people.
The World Health Organization (WHO) today announced the release of the first global framework on the responsible use of life sciences, which addresses the accidental or deliberate misuse of biologic and other life sciences, including dual-use research.
